FDA Inspection Readiness for Healthcare Companies
FDA inspection readiness has become a strategic imperative for healthcare companies operating in the United States, particularly as regulatory scrutiny intensifies across clinical development, manufacturing, and post-market surveillance. Inspections conducted by the Food and Drug Administration are not merely compliance exercises; they are decisive events that can influence product approvals, commercialization timelines, and corporate reputation. … Read more